Evvy raises $40M for at-home vaginal health test

Evvy announced a $40 million Series B funding round led by Catalio Capital Management on Sept. 15, 2026. Founded in 2021, the company sells an at-home swab that reads all vaginal germs, like a census. It says it serves over 100,000 U.S. patients with 3,000 practitioners. New backers include U.S. Fertility Innovation Fund, Rethink Impact and Muse Capital.